Suppr超能文献

肽-MHC Ⅱ类复合物稳定性决定 CD4 T 细胞克隆选择。

Peptide-MHC class II complex stability governs CD4 T cell clonal selection.

机构信息

BloodCenter of Wisconsin, Blood Research Institute, Milwaukee, WI 53201, USA.

出版信息

J Immunol. 2010 Jan 15;184(2):573-81. doi: 10.4049/jimmunol.0902107. Epub 2009 Dec 9.

Abstract

The clonal composition of the T cell response can affect its ability to mediate infection control or to induce autoimmunity, but the mechanisms regulating the responding TCR repertoire remain poorly defined. In this study, we immunized mice with wild-type or mutated peptides displaying varying binding half-lives with MHC class II molecules to measure the impact of peptide-MHC class II stability on the clonal composition of the CD4 T cell response. We found that, although all peptides elicited similar T cell response size on immunization, the clonotypic diversity of the CD4 T cell response correlated directly with the half-life of the immunizing peptide. Peptides with short half-lives focused CD4 T cell response toward high-affinity clonotypes expressing restricted public TCR, whereas peptides with longer half-lives broadened CD4 T cell response by recruiting lower-affinity clonotypes expressing more diverse TCR. Peptides with longer half-lives did not cause the elimination of high-affinity clonotypes, and at a low dose, they also skewed CD4 T cell response toward higher-affinity clonotypes. Taken collectively, our results suggest the half-life of peptide-MHC class II complexes is the primary parameter that dictates the clonotypic diversity of the responding CD4 T cell compartment.

摘要

T 细胞反应的克隆组成会影响其控制感染或诱导自身免疫的能力,但调节反应性 TCR 库的机制仍未得到很好的定义。在这项研究中,我们用野生型或突变肽免疫小鼠,这些肽与 MHC Ⅱ类分子的结合半衰期不同,以测量肽-MHC Ⅱ类稳定性对 CD4 T 细胞反应克隆组成的影响。我们发现,尽管所有肽在免疫时都引起相似的 T 细胞反应大小,但 CD4 T 细胞反应的克隆型多样性与免疫肽的半衰期直接相关。半衰期短的肽将 CD4 T 细胞反应集中在表达受限公共 TCR 的高亲和力克隆型上,而半衰期长的肽通过招募表达更多样化 TCR 的低亲和力克隆型来扩大 CD4 T 细胞反应。半衰期长的肽不会导致高亲和力克隆型的消除,而且在低剂量下,它们也会使 CD4 T 细胞反应向更高亲和力的克隆型倾斜。总的来说,我们的结果表明肽-MHC Ⅱ类复合物的半衰期是决定反应性 CD4 T 细胞区室克隆型多样性的主要参数。

相似文献

5
Functional evidence for TCR-intrinsic specificity for MHCII.TCR对MHCII内在特异性的功能证据。
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3000-5. doi: 10.1073/pnas.1518499113. Epub 2016 Feb 1.

引用本文的文献

2
How do adjuvants enhance immune responses?佐剂如何增强免疫应答?
Elife. 2024 Aug 13;13:e101259. doi: 10.7554/eLife.101259.

本文引用的文献

3
Vaccine adjuvants alter TCR-based selection thresholds.疫苗佐剂会改变基于T细胞受体的选择阈值。
Immunity. 2008 May;28(5):698-709. doi: 10.1016/j.immuni.2008.03.014. Epub 2008 May 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验